120 related articles for article (PubMed ID: 30387235)
1. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond.
Chibon F; Lesluyes T; Valentin T; Le Guellec S
Genes Chromosomes Cancer; 2019 Feb; 58(2):124-129. PubMed ID: 30387235
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
3. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
[TBL] [Abstract][Full Text] [Related]
5. A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
Lesluyes T; Chibon F
Cancer Res; 2020 Dec; 80(23):5282-5290. PubMed ID: 33023949
[TBL] [Abstract][Full Text] [Related]
6. The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms.
Lesluyes T; Delespaul L; Coindre JM; Chibon F
Sci Rep; 2017 Jul; 7(1):5480. PubMed ID: 28710396
[TBL] [Abstract][Full Text] [Related]
7. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.
Bertucci F; Niziers V; de Nonneville A; Finetti P; Mescam L; Mir O; Italiano A; Le Cesne A; Blay JY; Ceccarelli M; Bedognetti D; Birnbaum D; Mamessier E
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017155
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03).
Jakob J; Lesluyes T; Simeonova-Chergou A; Wenz F; Hohenberger P; Chibon F; Le Guellec S
Strahlenther Onkol; 2020 Mar; 196(3):280-285. PubMed ID: 31732782
[TBL] [Abstract][Full Text] [Related]
9. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.
Frezza AM; Stacchiotti S; Chibon F; Coindre JM; Italiano A; Romagnosa C; Bagué S; Dei Tos AP; Braglia L; Palmerini E; Quagliuolo V; Broto JM; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Beveridge RD; Lugowska I; Lesluyes T; Maestro R; Merlo FD; Casali PG; Gronchi A
Cancer Med; 2023 Jan; 12(2):1350-1357. PubMed ID: 35848358
[TBL] [Abstract][Full Text] [Related]
10. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
[TBL] [Abstract][Full Text] [Related]
11. CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
Brunac AC; Fourquet J; Perot G; Jaffrelot M; Meilleroux J; Danjoux M; Filleron T; Nicolaï V; Guimbaud R; Icher S; Farés N; Selves J; Chibon F
Mod Pathol; 2022 Dec; 35(12):2002-2010. PubMed ID: 36202996
[TBL] [Abstract][Full Text] [Related]
12. Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages.
Ferrari A; Iannó MF; Carenzo A; Fortunato O; Casanova M; Chiaravalli S; Bergamaschi L; Bertulli R; Cattaneo F; Collini P; Trama A; Sozzi G; Massimino M; De Cecco L; Gasparini P
Pediatr Blood Cancer; 2021 Jul; 68(7):e28987. PubMed ID: 33751795
[TBL] [Abstract][Full Text] [Related]
13. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.
Chibon F; Lagarde P; Salas S; Pérot G; Brouste V; Tirode F; Lucchesi C; de Reynies A; Kauffmann A; Bui B; Terrier P; Bonvalot S; Le Cesne A; Vince-Ranchère D; Blay JY; Collin F; Guillou L; Leroux A; Coindre JM; Aurias A
Nat Med; 2010 Jul; 16(7):781-7. PubMed ID: 20581836
[TBL] [Abstract][Full Text] [Related]
14. The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer.
Goncalves A; Finetti P; Birnbaum D; Bertucci F
NPJ Breast Cancer; 2021 May; 7(1):48. PubMed ID: 33953185
[TBL] [Abstract][Full Text] [Related]
15. [Grading of soft tissue and bone sarcomas].
Petersen I; Wardelmann E
Pathologe; 2016 Jul; 37(4):320-7. PubMed ID: 27384333
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in sarcoma cell lines reveals enhanced motility of tetraploid versus diploid cells.
Jemaà M; Abdallah S; Lledo G; Perrot G; Lesluyes T; Teyssier C; Roux P; van Dijk J; Chibon F; Abrieu A; Morin N
Oncotarget; 2017 Mar; 8(10):16669-16689. PubMed ID: 28035071
[TBL] [Abstract][Full Text] [Related]
17. Grading of soft tissue sarcomas: from histological to molecular assessment.
Neuville A; Chibon F; Coindre JM
Pathology; 2014 Feb; 46(2):113-20. PubMed ID: 24378389
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304.
Tanaka K; Hasegawa T; Nojima T; Oda Y; Mizusawa J; Fukuda H; Iwamoto Y
World J Surg Oncol; 2016 Apr; 14():110. PubMed ID: 27091124
[TBL] [Abstract][Full Text] [Related]
20. Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas.
Merry E; Thway K; Jones RL; Huang PH
NPJ Precis Oncol; 2021 Mar; 5(1):17. PubMed ID: 33674685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
